Monday, Nov 2 2020 | Time 19:50 Hrs(IST)
image
  • Panchayat Conference to contest on all DDC seats
  • Spurt in COVID may take place after 15- day following heavy inflow of travellers to Mysuru during Dasara: City DC
  • Capt should talk to PM to reverse decision on contentious farm laws:AAP
  • RTC bus services to be resumed between AP and Telangana
  • Satish Prasad Singh, CM for shortest tenure passes away
  • Punjab CM orders expansion of Covid contact tracing to 15 persons
  • Bihar gets prepared for second phase of Assembly Elections tomorrow
  • Four persons arrested in Ganderbal BJP attack case, investigation shifts to south Kashmir
  • IPL 2020: DC win toss, elect to bowl against RCB
  • Biennial UP legislative council polls for 11 seats to be held on Dec 1
  • RSP achieves several production records in key areas in October
  • Badshah of Bollywood Shah Rukh Khan turns 55
  • Kenyan CDF in India to cement bilateral defence ties
  • Ajit Pawar discharged from hospital
  • Elaborate arrangements for by election in Balasore and Tirtol Assembly seats in Odisha
Business Economy


Bandhan Bank records impressive business growth

Kolkata, Nov 02 (UNI) Bandhan Bank, the universal bank with inclusive banking at its core, today announced its financial results for the second quarter of financial year 2020-21 with its total
business (deposits and advances) growing 25.90 per cent year-on-year to reach Rs. 1,42,742.3
crore.
The Bank started operations in FY15-16 and completed five years of operations in August this
year. In just a little over 5 years, the Bank has 4,701 banking outlets through which it serves 2.08
crore customers. The total number of employees working at Bandhan Bank stands at 45,549.
With the country gradually unlocking its economy, the Bank’s deposit book grew 34.4% over the corresponding quarter of the previous year.
The total deposits now stand at Rs. 66,127.7 crore. The current account + savings account
(CASA) book grew by 56.2% year-on-year to Rs.25,279 crore and CASA ratio now stands at
38.2% of the overall deposit book.
With respect to advances, the Bank saw 19.4% growth over the corresponding quarter of the
previous year.
The total advances are now at Rs. 76,614.6 crore. The net NPA of the Bank stands at a low
0.4%, signifying a quality loan book.
Capital Adequacy Ratio (CAR), an indication of the stability of the Bank, is at 27.8%, including
profits, much higher than the required level. The Bank’s net profit stood at Rs.920 crore, up 67.3%
over the previous quarter ended June 30, 2020.
Speaking on the results, Chandra Shekhar Ghosh, MD & CEO, said, “After a complete lockdown
in the first quarter of the financial year, the second quarter was better with several parts of the
country opening up for economic activity. Our growth is thanks to the trust and confidence reposed
in us by all our customers, who have shown resilience in the face of economic challenges. The
Bank, through its employees, remains committed to serve our customers better and also make
some meaningful contribution towards the society and the economy.”
UNI SJC BM
More News

RSP achieves several production records in key areas in October

02 Nov 2020 | 7:21 PM

Bhubaneswar, Nov 2 (UNI) Rourkela Steel Plant (RSP), a unit of the Maharatna company
SAIL has set several new production records in various key areas in October 2020.

see more..

RPX Corporation and Conversant Wireless Licensing S à r l Announce Licensing Transaction

02 Nov 2020 | 7:19 PM

SAN FRANCISCO, Nov. 2, 2020 /PRNewswire/ -- Today, RPX and Conversant Wireless S.à r.l. announced an agreement that provides a subset of the RPX membership with a license to Conversant Wireless' portfolio of wireless patents, including a substantial number of Standard Essential Patents. Conversant Wireless acquired these assets from Nokia in 2011.

see more..

RevImmune advances new immunotherapy in COVID-19

02 Nov 2020 | 7:15 PM

BETHESDA, Maryland, Nov. 2, 2020 /PRNewswire/ -- RevImmune, a privately held biotech company based in Paris, France and Bethesda, MD, developing CYT107 (recombinant human Interleukin-7) for infectious diseases, sepsis and cancer, announced today that its "ILIAD-7" international randomized controlled Phase 2 trial in patients critically ill with COVID-19, is now enrolling patients at 5 sites in the U.S. The trial has already been under way for some time in the U.K. and France and is about to start in Brazil.

see more..

Agbotic Establishes Regenerative Agriculture Initiative in Europe

02 Nov 2020 | 7:13 PM

Leading Farm, Food, and Retail Corporations Investing in Carbon Drawdown
NEW YORK, Nov. 2, 2020 /PRNewswire/ -- Agbotic, the leader in regenerative SmartFarm technology, announced the establishment of Agbotic Limited in Dublin, Ireland, to conduct business across Europe.

see more..

Leading KSA Real Estate Developer Dar Al Arkan launches its first project in Europe

02 Nov 2020 | 7:12 PM

RIYADH, Saudi Arabia, Nov. 2, 2020 /PRNewswire/ -- Dar Al Arkan, the leading real estate development company in KSA, has announced the launch of its first European residential project. The 500,000 sqm luxury development will be located in Bosnia and Herzegovina within a stunning forest just 30 minutes from the country's capital, Sarajevo. The project is slated to break ground in the early part of 2021.

see more..
image